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Diabetes mellitus is the commonest metabolic disorder and has a high prevalence in India. Diabetic 
nephropathy is characterized by proteinuria and is the leading cause of end stage renal disease. The prevalence of 
microalbuminuria predicts progression to diabetic nephropathy. This cross sectional study was carried out in the 
diabetic clinic at SVMCH and RC. Sixty known Type 2 diabetic patients with age 30-70 years of both genders were 
included in the study. Fasting, postprandial venous blood and morning urine sample was collected for analysis of 
blood glucose, HbA1c and microalbuminuria levels. Statistical analysis was done using SPSS version 17.0. Pearson 
correlation and Chi square test was applied to observe association of microalbuminuria with different parameters.  
P-value < 0.05 was considered as statistically significant. Our study showed that about 70% of the patients had 
HbA1c >7% and 48% of the patients had Microalbuminuria (≥30mg/day). Almost 45% of the patients with HbA1c 
>7% had Microalbuminuria (≥30mg/day) which indicates persistent increase in glycated haemoglobin and 
microalbuminuria may be considered as risk factor in diabetic nephropathy. Therefore, regular screening for 
microalbuminuria and HbA1c testing should be done in diabetic patients as an early marker of renal risk factor. 
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Diabetes Mellitus is an important metabolic disorder worldwide and is characterized by 
variable degree of insulin resistance, impaired insulin secretion & increased glucose levels.[1] 
Overall prevalence of  diabetes is expected to increase worldwide by 122% (from 135 million to 
300 million people) between 1995 and 2025; 90% of these people will have type 2 Diabetes.[2] 
The glycated hemoglobin (HbA1c) assay is the most commonly used measure of chronic 
glycaemia, since its introduction more than 25 years ago.[3]  HbA1c levels in diabetes for a good 
control will be 6.5% and that of 7.5% will be of greater risk.[4]   
 
Proteinuria is a key feature of diabetic nephropathy, a strong predictor of progression 
towards end stage renal failure. Proteinuria independently associates with coronary heart 
disease in patients with diabetes and reflects not only renal impairment and a key pathogenic 
element of disease progression, but also more generalized vascular damage.[5] Normally 
microalbumin 30-300mg/day or 20-200µg/min in 24 hours urine collection is characterized as 
microalbuminuria and the patient with microalbuminuria are referred to have incipient 
nephropathy.[6] Microalbuminuria is defined as an increase in urine albumin excretion above 
normal, but which is not detectable by conventional dip-stick testing, whilst proteinuria 
represents an increase in urine albumin that is detectable by conventional dip-stick testing. 
HbA1c levels are higher in diabetic patients who develop micro- and macroalbuminuria, and 
there is strong prospective evidence that poor blood glucose control contributes to the 
development of albuminuria. Open analysis of UKPDS data suggested that for a 1% reduction in 
HbA1c, there significantly (HbA1c 7.5-6.6%) in those whose albumin excretion reverted to 
normal, and HbA1c was significantly higher than in those who remained microalbuminuric 
(HbA1c7.7%) or developed proteinuria (HbA1c8.9). [7]  
Allawi et al, Ko et al, Mather et al and Vijay et al. reported the prevalence of microalbuminuria 
among 600 type 2 diabetic patients in Chennai.[8] Huraib et al. carried out study relating 
prevalence of microalbuminuria with urine albumin to creatinine ratio.[9]  Varghese et al. 
carried out study among type 2 diabetic people and found a positive correlation between 
microalbuminuria and HbA1c but did not find any statistical difference between 
microalbuminuria and two sexes.[10] This study was undertaken to assess the HbA1c and 
microalbumin levels and thereby to assess the correlation between HbA1c and 
microalbuminuria, which is a risk factor and an early indicator of diabetic nephropathy in Type 2 
diabetes patients. 
 
AIM AND OBJECTIVES 
 
1. To estimate the HbA1c levels among known type 2 Diabetic patients and the prevalence of 
Microalbuminuria among them.  
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MATERIALS AND METHODS 
 
This cross sectional study was done among 60 known Type 2 diabetic patients attending 
medicine out-patient department at SVMCH & RC, Pondicherry. Institutional Ethical Committee 
Clearance and written informed consent was obtained.  
 
Patients with duration of Diabetes of  ≥5 years, age between 30 – 70 years of either 
gender were included. Patients with systemic diseases like cardiovascular diseases, 
cerebrovascular diseases , urinary tract infection and type I diabetes mellitus was excluded 
from the study.  
 
Fasting and 2 hour postprandial venous blood samples were collected for estimation of 
blood glucose levels. The fasting blood sample with EDTA was used to estimate HbA1c levels 
using Affinity Chromatography method. A morning urine sample was used for estimating the 
microalbumin levels by Immunoturbidity  method. HbA1c levels <7% were considered to be 




Datas were analysed using SPSS version17.0.  Pearson correlation coefficient  was 
calculated to find the linear relation between Hb A1c and microalbuminuria. Chi square test  was 
also used to find out relationship between HbA1c and microalbuminuria. P value was taken as 




 Among 60 known diabetic patients 65% were males and 35% females (Figure1). Table 1 
summarizes the baseline and laboratory parameters. The mean age was 54±12.7 years. The 
mean duration of diabetes was 7.2±5.8 years. The mean of HbA1c was 8.5± 2.2 % and mean 
microalbumin was 26.3± 13.1 mg/day. Our study revealed that out of 60 diabetic patients 42 
(70%)had HbA1c ≥ 7%  and 18(30%) had less than 7%. Microalbuminuria was found among 29 
(48%) patients. 
 
Table 1: Baseline and laboratory parameters of the study groups (n= 60) 
 
 Minimum Maximum Mean Standard Deviation 
Age 31.00 77.00 53.9833 12.74322 
FBS 11.80 156.00 124.9467 20.59376 
PPBS 120.00 235.00 170.3333 30.57287 
HbA1c 5.06 13.50 8.4838 2.21972 
Microalbumin 8.80 59.00 26.2467 13.11371 
 
A positive correlation was found among 25(45%) diabetic patients with uncontrolled 
glycaemic status which is shown by HbA1c ≥ 7% and microalbuminuria indicated by >30mg/day 
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and this was evidenced by Pearson’s correlation coefficient (r= 0.5590) and Chi square test.  







Figure1 – Gender distribution
 
 










≤7% 13 5 
>7% 18 24 
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Diabetic nephropathy is one of the most serious long-term complications of diabetes 
mellitus. Various epidemiological studies and cross-sectional studies have reported many 
variations in prevalence of microalbuminuria. Vijay et al. reported a prevalence of 15.7% in 600 
type 2 diabetic patients in Chennai. [8]   Huraib et al reported a prevalence of 16.8% among 125 
type 2 diabetic patients in Saudi Arabia. [9] Varghese et al. reported a prevalence of 36.3% in 
1425 type 2 diabetic patients in Chennai. [10] The variation in the prevalence of 
microalbuminuria can be attributed to several factors such as difference in population, the 
definition of microalbuminuria, the methods of measurement of microalbuminuria and urine 
collection etc. Huraib et al. also used immunoturbidity method for the assessment of 
microalbuminuria[9] which is the same method followed in the present study. 
 
In our study among 60 known diabetic patients, the prevalence of microalbuminuria 
with high HbA1c which was estimated to be statistically significant with a correlation of 45% 
(p<0.05). We also found that all patients with uncontrolled glycaemia was found to have a 
positive correlation with microalbuminuria. Thus in our study the correlation was found to be 




It was concluded that the prevalence of microalbuminuria in diabetic patients in this 
study was found to be as high as 45%, which needs of therapeutic and preventive measures. 
Being a developing country, there is a  need of  microalbuminuria and HbA1c testing in both 
newly diagnosed as well as already diagnosed type 2 diabetic patients as an early marker of 
renal risk factor. The present study emphazises education about strict glycaemic control and 
testing for microalbuminuria which is an early indicator of diabetic nephropathy, mandatory for 
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